Inventor · disambiguated record
Scott D. Kuduk
Also filed as: KUDUK SCOTT · KUDUK SCOTT D
118 granted patents·38 pending applications·883 citations·filing 1998–2023
99Inventor score
Files withMERCK SHARP & DOHME51NOVIRA THERAPEUTICS INC24KUDUK SCOTT D23BESHORE DOUGLAS C10JANSSEN SCIENCES IRELAND UNLIMITED CO10
Top patents by PatentIndex Score
156 records- 0199US9181288B2Azepane derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Nov 10, 2015·103 cites·6 claims
- 0298US9339510B2Azepane derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·25 cites·20 claims
- 0397US9586934B22-pyridyloxy-4-methyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Mar 7, 2017·25 cites·14 claims
- 0497US9550779B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Jan 24, 2017·10 cites·17 claims
- 0597US9527845B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Dec 27, 2016·11 cites·19 claims
- 0697US9518057B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Dec 13, 2016·10 cites·20 claims
- 0796US9624197B22-pyridylamino-4-nitrile-piperidinyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Apr 18, 2017·24 cites·11 claims
- 0896US9617246B2Thioether-piperidinyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Apr 11, 2017·18 cites·14 claims
- 0996US9556190B2Piperidinyloxy lactone orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jan 31, 2017·18 cites·16 claims
- 1096US9505722B2Azepane derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·24 cites·20 claims
- 1196US9169212B2Azepane derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2014·Granted Oct 27, 2015·28 cites·20 claims
- 1296US8940898B2Piperidinyl alkyne orexin receptor antagonistsKUDUK SCOTT D·Filed 2012·Granted Jan 27, 2015·25 cites·16 claims
- 1395US9586950B22-pyridyloxy-3-ester-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Mar 7, 2017·17 cites·12 claims
- 1495US9556145B22-pyridyloxy-4-ester orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·17 cites·15 claims
- 1595US9550786B24-fluoropiperidine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jan 24, 2017·17 cites·12 claims
- 1695US9546152B22-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 17, 2017·17 cites·13 claims
- 1795US6204388B1Synthesis of epothilones, intermediates thereto and analogues thereofSLOAN KETTERING INST CANCER·Filed 1999·Granted Mar 20, 2001·143 cites·9 claims
- 1894US9156819B22-pyridyloxy-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2012·Granted Oct 13, 2015·34 cites·28 claims
- 1993US9029364B22,5-disubstituted thiomorpholine orexin receptor antagonistsKUDUK SCOTT D·Filed 2012·Granted May 12, 2015·30 cites·15 claims
- 2092US10544141B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·2 cites·21 claims
- 2192US10538519B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·2 cites·13 claims
- 2292US10189835B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2017·Granted Jan 29, 2019·2 cites·18 claims
- 2392US10011595B2Ethyldiamine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·7 cites·10 claims
- 2492US8664234B2Dihydrobenzoquinazolinone M1 receptor positive allosteric modulatorsKUDUK SCOTT D·Filed 2011·Granted Mar 4, 2014·11 cites·17 claims
- 2591US10556904B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2018·Granted Feb 11, 2020·2 cites·20 claims
- 2691US10093669B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2016·Granted Oct 9, 2018·2 cites·10 claims
- 2791US10077264B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2016·Granted Sep 18, 2018·2 cites·17 claims
- 2891US9890161B2Derivatives and methods of treating hepatitis B infectionsNOVIRA THERAPEUTICS INC·Filed 2016·Granted Feb 13, 2018·3 cites·18 claims
- 2989US11753393B2Dihydroorotate dehydrogenase inhibitorsJANSSEN BIOTECH INC·Filed 2022·Granted Sep 12, 2023·1 cites·8 claims
- 3089US6670348B1Methods and compositions for destruction of selected proteinsSLOAN KETTERING INST CANCER·Filed 1998·Granted Dec 30, 2003·85 cites·40 claims
- 3188US8697690B2Isoindolone M1 receptor positive allosteric modulatorsBESHORE DOUGLAS C·Filed 2011·Granted Apr 15, 2014·7 cites·17 claims
- 3287US8383638B2Aminobenzoquinazolinone M1 receptor positive allosteric modulatorsMERCK SHARP & DOHME·Filed 2010·Granted Feb 26, 2013·6 cites·22 claims
- 3385US6603023B2Synthesis of epothilones, intermediates thereto and analogues thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Aug 5, 2003·12 cites·23 claims
- 3483US9695163B2Thiazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jul 4, 2017·8 cites·14 claims
- 3583US9676751B22-amino-3-ester-pyridl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jun 13, 2017·3 cites·14 claims
- 3682US9732077B2Diazepane orexin receptor antagonistsKUDUK SCOTT D·Filed 2014·Granted Aug 15, 2017·3 cites·13 claims
- 3782US7160856B2α-O-linked glycoconjugates, methods of preparation and uses thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Jan 9, 2007·17 cites·47 claims
- 3881US11505536B2Dihydroorotate dehydrogenase inhibitorsJANSSEN BIOTECH INC·Filed 2020·Granted Nov 22, 2022·1 cites·31 claims
- 3981US6919343B2N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivativesMERCK & CO INC·Filed 2003·Granted Jul 19, 2005·14 cites·40 claims
- 4080US9938276B26,5-bicyclic octahydropyrrolopyridine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Apr 10, 2018·2 cites·11 claims
- 4180US9725434B2Hydroxy-substituted orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Aug 8, 2017·3 cites·12 claims
- 4279US9745284B22-pyridyloxy-4-ether orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Aug 29, 2017·2 cites·6 claims
- 4379US9273033B2Substituted pyridone derivatives as PDE10 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 1, 2016·2 cites·17 claims
- 4479US6660714B1α-O-linked glycoconjugates, methods of preparation and uses thereofSLOAN KETTERING INST CANCER·Filed 1998·Granted Dec 9, 2003·36 cites·58 claims
- 4578US9765057B23-ester-4 substituted orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Sep 19, 2017·2 cites·11 claims
- 4678US9643955B22-pyridyloxy-3-nitrile-4-substituted orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted May 9, 2017·2 cites·10 claims
- 4778US8883810B2Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Nov 11, 2014·2 cites·15 claims
- 4877US8772276B2Alkyne benzotriazole derivativesKUDUK SCOTT D·Filed 2012·Granted Jul 8, 2014·2 cites·17 claims
- 4977US8293744B2Heterocyclic fused cinnoline M1 receptor positive allosteric modulatorsKUDUK SCOTT D·Filed 2010·Granted Oct 23, 2012·2 cites·19 claims
- 5077US8273737B2Quinolizidinone M1 receptor positive allosteric modulatorsKUDUK SCOTT D·Filed 2009·Granted Sep 25, 2012·3 cites·19 claims
Showing the top 50 of 156 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Scott D. Kuduk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →